Inebilizumab, CAS [[1299440-37-1]]

Produktübersicht

• Artikelname: Inebilizumab, CAS [[1299440-37-1]]
• Artikelnummer: TGM-T76713
• Hersteller Artikelnummer: T76713
• Alternativnummer: TGM-T76713-1MG, TGM-T76713-5MG, TGM-T76713-10MG, TGM-T76713-25MG, TGM-T76713-50MG, TGM-T76713-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: VIB-0551, MEDI 551, MT-0551, 16C4-aFuc

Produktbeschreibung

Inebilizumab is a humanized anti-CD19 monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used to treat a range of autoimmune diseases associated with CD19 B cells, such as multiple scleros

Produkteigenschaften

• CAS Nummer: [1299440-37-1]
• Target-Kategorie: ADC Antibody|||Others